Study: 2 Million People with Heart Disease Estimated to Have Used Marijuana
February 3rd 2020A recent study estimates that approximately 2 million adults in the United States who have cardiovascular disease currently use marijuana or have used the drug in the past. This estimate is based on responses from the National Health and Nutrition Examination Survey from 2016.
Read More
Low-Dose Colchicine Post-MI: Reducing Inflammation?
February 3rd 2020Canakinumab, a fully human monoclonal antibody, targets interleukin-1β, has anti-inflammatory effects, and is FDA-approved for rheumatologic disorders. Interleukein-1β is a cytokine that drives the interleukin(IL)-6 signaling pathway in inflammatory response.
Read More
FDA Awards Orphan Drug Designation to Losmapimod for Treatment of FSHD
January 30th 2020Although there are no approved therapies for FSHD, researchers at Fulcrum Therapeutics discovered that inhibition of p38α/β reduced expression of the DUX4 gene in muscle cells derived from patients with FSHD.
Read More
Intravenous Iron Receives FDA Approval for Adults with Iron Deficiency Anemia
January 30th 2020Iron deficiency anemia is a condition that affects nearly 1 billion people globally,1 in which the blood lacks adequate healthy red blood cells, often leaving those with the condition tired and short of breath.2
Read More